• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

源自鲍曼不动杆菌噬菌体内溶素 LysAB2 的高效抗菌修饰肽。

Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2.

机构信息

Department of Laboratory Medicine and Biotechnology, Tzu Chi University, Hualien, Taiwan.

Department of Biochemistry, Tzu Chi University, Hualien, Taiwan.

出版信息

Sci Rep. 2017 Sep 13;7(1):11477. doi: 10.1038/s41598-017-11832-7.

DOI:10.1038/s41598-017-11832-7
PMID:28904355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5597585/
Abstract

The increase in the prevalence of multidrug-resistant Acinetobacter baumannii (MDRAB) strains is a serious public health concern. Antimicrobial peptides (AMPs) are a possible solution to this problem. In this study, we examined whether AMPs could be derived from phage endolysins. We synthesized four AMPs based on an amphipathic helical region in the C-terminus of endolysin LysAB2 encoded by the A. baumannii phage ΦAB2. These peptides showed potent antibacterial activity against A. baumannii (minimum inhibitory concentration, 4-64 μM), including some MDR and colistin-resistant A. baumannii. Of the four peptides, LysAB2 P3, with modifications that increased its net positive charge and decreased its hydrophobicity, showed high antibacterial activity against A. baumannii but little haemolytic and no cytotoxic activity against normal eukaryotic cells. The results of electron microscopy experiments and a fluorescein isothiocyanate staining assay indicated that this peptide killed A. baumannii through membrane permeabilization. Moreover, in a mouse intraperitoneal infection model, at 4 h after the bacterial injection, LysAB2 P3 decreased the bacterial load by 13-fold in ascites and 27-fold in blood. Additionally, LysAB2 P3 rescued sixty percent of mice heavily infected with A. baumannii from lethal bacteremia. Our results confirmed that bacteriophage endolysins are a promising resource for developing effective AMPs.

摘要

多药耐药鲍曼不动杆菌(MDRAB)菌株的流行率增加是一个严重的公共卫生问题。抗菌肽(AMPs)是解决这一问题的一种可能的方法。在这项研究中,我们研究了 AMP 是否可以从噬菌体内溶素衍生而来。我们基于编码于 A. baumannii 噬菌体 ΦAB2 的内溶素 LysAB2 的 C 末端的一个两亲性螺旋区域,合成了四个 AMP。这些肽对 A. baumannii 具有很强的抗菌活性(最小抑菌浓度,4-64 μM),包括一些 MDR 和多粘菌素耐药的 A. baumannii。在这四个肽中,LysAB2 P3 经过修饰,增加了净正电荷,降低了疏水性,对 A. baumannii 具有很高的抗菌活性,但对正常真核细胞的溶血和细胞毒性作用很小。电子显微镜实验和荧光素异硫氰酸酯染色试验的结果表明,这种肽通过破坏细胞膜来杀死 A. baumannii。此外,在小鼠腹腔感染模型中,在细菌注射后 4 小时,LysAB2 P3 使腹水和血液中的细菌负荷分别减少了 13 倍和 27 倍。此外,LysAB2 P3 使 60%感染严重的 A. baumannii 的小鼠免于致命性菌血症。我们的结果证实了噬菌体内溶素是开发有效 AMP 的有前途的资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b3/5597585/673dd5181d7f/41598_2017_11832_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b3/5597585/71abc556ec7f/41598_2017_11832_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b3/5597585/992562b3bf84/41598_2017_11832_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b3/5597585/8414aba9203b/41598_2017_11832_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b3/5597585/e7dd22660543/41598_2017_11832_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b3/5597585/bdda5c73c307/41598_2017_11832_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b3/5597585/d47f6f0be92c/41598_2017_11832_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b3/5597585/673dd5181d7f/41598_2017_11832_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b3/5597585/71abc556ec7f/41598_2017_11832_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b3/5597585/992562b3bf84/41598_2017_11832_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b3/5597585/8414aba9203b/41598_2017_11832_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b3/5597585/e7dd22660543/41598_2017_11832_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b3/5597585/bdda5c73c307/41598_2017_11832_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b3/5597585/d47f6f0be92c/41598_2017_11832_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b3/5597585/673dd5181d7f/41598_2017_11832_Fig7_HTML.jpg

相似文献

1
Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2.源自鲍曼不动杆菌噬菌体内溶素 LysAB2 的高效抗菌修饰肽。
Sci Rep. 2017 Sep 13;7(1):11477. doi: 10.1038/s41598-017-11832-7.
2
Antibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both gram-positive and gram-negative bacteria.鲍曼不动杆菌噬菌体 ϕAB2 溶菌酶 (LysAB2) 对革兰氏阳性菌和革兰氏阴性菌的抗菌活性。
Appl Microbiol Biotechnol. 2011 Apr;90(2):529-39. doi: 10.1007/s00253-011-3104-y. Epub 2011 Jan 25.
3
Characterization of a Novel Phage ΦAb1656-2 and Its Endolysin with Higher Antimicrobial Activity against Multidrug-Resistant .新型噬菌体 ΦAb1656-2 及其溶菌酶的特性研究,该溶菌酶对多药耐药 具有更高的抗菌活性。
Viruses. 2021 Sep 16;13(9):1848. doi: 10.3390/v13091848.
4
Antibacterial properties of Acinetobacter baumannii phage Abp1 endolysin (PlyAB1).鲍曼不动杆菌噬菌体Abp1溶菌酶(PlyAB1)的抗菌特性
BMC Infect Dis. 2014 Dec 12;14:681. doi: 10.1186/s12879-014-0681-2.
5
Membrane-Permeable Antibacterial Enzyme against Multidrug-Resistant .细胞膜通透型抗多重耐药抗菌酶
ACS Infect Dis. 2021 Aug 13;7(8):2192-2204. doi: 10.1021/acsinfecdis.1c00222. Epub 2021 Jul 7.
6
Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa.新型噬菌体溶菌酶 LysSS 对鲍曼不动杆菌和铜绿假单胞菌的抗菌活性。
J Glob Antimicrob Resist. 2020 Sep;22:32-39. doi: 10.1016/j.jgar.2020.01.005. Epub 2020 Jan 30.
7
Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infections.抗菌肽作为一种有前途的治疗鲍曼不动杆菌感染的方法。
Microb Pathog. 2020 Sep;146:104238. doi: 10.1016/j.micpath.2020.104238. Epub 2020 May 5.
8
Antimicrobial peptide thanatin fused endolysin PA90 (Tha-PA90) for the control of Acinetobacter baumannii infection in mouse model.抗菌肽 thanatin 融合内溶素 PA90(Tha-PA90)用于控制小鼠模型中的鲍曼不动杆菌感染。
J Biomed Sci. 2024 Apr 15;31(1):36. doi: 10.1186/s12929-024-01027-4.
9
Bacteriophages, phage endolysins and antimicrobial peptides - the possibilities for their common use to combat infections and in the design of new drugs.噬菌体、噬菌体溶菌酶和抗菌肽——它们联合用于对抗感染及新药设计的可能性。
Ann Agric Environ Med. 2019 Jun 17;26(2):203-209. doi: 10.26444/aaem/105390. Epub 2019 Apr 11.
10
Identification and characterisation of the putative phage-related endolysins through full genome sequence analysis in Acinetobacter baumannii ATCC 17978.通过对鲍曼不动杆菌 ATCC 17978 的全基因组序列分析鉴定和特性分析潜在噬菌体相关内溶素。
Int J Antimicrob Agents. 2013 Aug;42(2):141-8. doi: 10.1016/j.ijantimicag.2013.04.022. Epub 2013 Jun 3.

引用本文的文献

1
Expanding structural insights into DNA packaging apparatus and endolysin LysSA05 function of Epsilon15 bacteriophage.拓展对Epsilon15噬菌体DNA包装装置和内溶素LysSA05功能的结构认识。
Front Cell Infect Microbiol. 2025 Aug 14;15:1643576. doi: 10.3389/fcimb.2025.1643576. eCollection 2025.
2
Phage and enzyme therapies in wound infections: From lab to bedside.伤口感染中的噬菌体和酶疗法:从实验室到临床
Chin Med J (Engl). 2025 Sep 5;138(17):2102-2115. doi: 10.1097/CM9.0000000000003626. Epub 2025 Aug 4.
3
Phage and Endolysin Therapy Against Antibiotics Resistant Bacteria: From Bench to Bedside.

本文引用的文献

1
Novel Engineered Peptides of a Phage Lysin as Effective Antimicrobials against Multidrug-Resistant Acinetobacter baumannii.噬菌体裂解素的新型工程肽作为抗多重耐药鲍曼不动杆菌的有效抗菌剂
Antimicrob Agents Chemother. 2016 Apr 22;60(5):2671-9. doi: 10.1128/AAC.02972-15. Print 2016 May.
2
Peptides with dual mode of action: Killing bacteria and preventing endotoxin-induced sepsis.具有双重作用模式的肽:杀死细菌并预防内毒素诱导的败血症。
Biochim Biophys Acta. 2016 May;1858(5):971-9. doi: 10.1016/j.bbamem.2016.01.011. Epub 2016 Jan 20.
3
APD3: the antimicrobial peptide database as a tool for research and education.
噬菌体和溶菌酶治疗耐药细菌:从实验室到临床应用
MedComm (2020). 2025 Jul 13;6(7):e70280. doi: 10.1002/mco2.70280. eCollection 2025 Jul.
4
Endolysins and membrane-active peptides: innovative engineering strategies against gram-negative bacteria.内溶素和膜活性肽:针对革兰氏阴性菌的创新工程策略。
Front Microbiol. 2025 Jun 3;16:1603380. doi: 10.3389/fmicb.2025.1603380. eCollection 2025.
5
Advances in Antimicrobial Peptides: Mechanisms, Design Innovations, and Biomedical Potential.抗菌肽的进展:作用机制、设计创新及生物医学潜力
Molecules. 2025 Mar 29;30(7):1529. doi: 10.3390/molecules30071529.
6
Surface charge of the C-terminal helix is crucial for antibacterial activity of endolysin against Gram-negative bacteria.C 端螺旋的表面电荷对于内溶素抗革兰氏阴性菌的抗菌活性至关重要。
J Biomed Sci. 2025 Mar 22;32(1):38. doi: 10.1186/s12929-025-01133-x.
7
Development of Chimera AMP-Endolysin with Wider Spectra Against Gram-Negative Bacteria Using High-Throughput Assay.利用高通量检测技术开发对革兰氏阴性菌具有更广泛谱的嵌合AMP-内溶素
Viruses. 2025 Jan 30;17(2):200. doi: 10.3390/v17020200.
8
Bactericidal Effect of a Novel Phage Endolysin Targeting Multi-Drug-Resistant .一种新型噬菌体溶菌酶对多重耐药菌的杀菌作用
Antibiotics (Basel). 2025 Feb 6;14(2):162. doi: 10.3390/antibiotics14020162.
9
The Unique Capability of Endolysin to Tackle Antibiotic Resistance: Cracking the Barrier.内溶素应对抗生素耐药性的独特能力:突破障碍
J Xenobiot. 2025 Jan 25;15(1):19. doi: 10.3390/jox15010019.
10
Diversity of Endolysin Domain Architectures in Bacteriophages Infecting Bacilli.感染芽孢杆菌的噬菌体中内溶素结构域结构的多样性
Biomolecules. 2024 Dec 11;14(12):1586. doi: 10.3390/biom14121586.
APD3:作为研究与教育工具的抗菌肽数据库
Nucleic Acids Res. 2016 Jan 4;44(D1):D1087-93. doi: 10.1093/nar/gkv1278. Epub 2015 Nov 23.
4
Gram-positive bacterial cell envelopes: The impact on the activity of antimicrobial peptides.革兰氏阳性菌的细胞壁包膜:对抗菌肽活性的影响。
Biochim Biophys Acta. 2016 May;1858(5):936-46. doi: 10.1016/j.bbamem.2015.11.004. Epub 2015 Nov 11.
5
Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model.新型噬菌体裂解酶能够在小鼠菌血症模型中杀死多重耐药革兰氏阴性菌鲍曼不动杆菌。
Antimicrob Agents Chemother. 2015 Apr;59(4):1983-91. doi: 10.1128/AAC.04641-14. Epub 2015 Jan 20.
6
Identification and characterisation of the putative phage-related endolysins through full genome sequence analysis in Acinetobacter baumannii ATCC 17978.通过对鲍曼不动杆菌 ATCC 17978 的全基因组序列分析鉴定和特性分析潜在噬菌体相关内溶素。
Int J Antimicrob Agents. 2013 Aug;42(2):141-8. doi: 10.1016/j.ijantimicag.2013.04.022. Epub 2013 Jun 3.
7
Characterization of the polymyxin B resistome of Pseudomonas aeruginosa.铜绿假单胞菌多粘菌素 B 耐药组的特征。
Antimicrob Agents Chemother. 2013 Jan;57(1):110-9. doi: 10.1128/AAC.01583-12. Epub 2012 Oct 15.
8
Ancient antimicrobial peptides kill antibiotic-resistant pathogens: Australian mammals provide new options.古老的抗菌肽能杀死抗药性的病原体:澳大利亚哺乳动物提供了新的选择。
PLoS One. 2011;6(8):e24030. doi: 10.1371/journal.pone.0024030. Epub 2011 Aug 30.
9
Antibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both gram-positive and gram-negative bacteria.鲍曼不动杆菌噬菌体 ϕAB2 溶菌酶 (LysAB2) 对革兰氏阳性菌和革兰氏阴性菌的抗菌活性。
Appl Microbiol Biotechnol. 2011 Apr;90(2):529-39. doi: 10.1007/s00253-011-3104-y. Epub 2011 Jan 25.
10
Potent and rapid bactericidal action of alyteserin-1c and its [E4K] analog against multidrug-resistant strains of Acinetobacter baumannii.阿利特西林-1c 及其 [E4K]类似物对多重耐药鲍曼不动杆菌的强大且快速杀菌作用。
Peptides. 2010 Oct;31(10):1806-10. doi: 10.1016/j.peptides.2010.06.032. Epub 2010 Jul 11.